Showing 161 - 180 results of 1,447 for search '"liver disease"', query time: 0.06s Refine Results
  1. 161

    Liver HLA-E Expression Is Associated with Severity of Liver Disease in Chronic Hepatitis C by Roberta C. Araújo, Fabricio C. Dias, Bruna C. Bertol, Deisy M. Silva, Patrícia H. Almeida, Andreza C. Teixeira, Fernanda F. Souza, Marcia G. Villanova, Leandra N. Z. Ramalho, Eduardo A. Donadi, Ana L. C. Martinelli

    Published 2018-01-01
    “…Human leukocyte antigen E (HLA-E) might regulate the antiviral function of immune response and contribute to the persistence of HCV and the severity of liver disease. This study aimed to evaluate the expression of HLA-E in the liver and its association with the severity of liver disease in HCV patients. …”
    Get full text
    Article
  2. 162

    Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur” by Abdulrahman Ismaiel, Stefan-Lucian Popa, Dan L. Dumitrascu

    Published 2020-01-01
    “…Both nonalcoholic fatty liver disease (NAFLD) and ischemic heart disease have common pathogenic links. …”
    Get full text
    Article
  3. 163
  4. 164

    Increased Porphyrins in Primary Liver Cancer Mainly Reflect a Parallel Liver Disease by Jerzy Kaczynski, Göran Hansson, Sven Wallerstedt

    Published 2009-01-01
    “…We conclude that symptomatic porphyries are unusual in PLC, whereas elevated urinary and/or faecal porphyrins are common, primarily reflecting a parallel liver disease and not the PLC.…”
    Get full text
    Article
  5. 165
  6. 166
  7. 167

    Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease by Hongjie Ou, Yaojie Fu, Wei Liao, Caixia Zheng, Xiaolu Wu

    Published 2019-01-01
    “…We aimed at analyzing the role of smoking in hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) and at exploring the related risk factors. …”
    Get full text
    Article
  8. 168

    Noninvasive Methods, including Transient Elastography, for the Detection of Liver Disease in Adults with Cystic Fibrosis by Matthew D Sadler, Pam Crotty, Linda Fatovich, Stephanie Wilson, Harvey R Rabin, Robert P Myers

    Published 2015-01-01
    “…BACKGROUND: Liver disease is the third leading cause of mortality in patients with cystic fibrosis (CF). …”
    Get full text
    Article
  9. 169

    Biochemical Features of Alcohol-Induced Liver Disease in Native Versus Non-Native Canadians by GY Minuk, W Thompson

    Published 1990-01-01
    “…The results of this study indicate that alcoholic liver disease in native Canadians is associated with higher serum alkaline phosphatase levels than in non-native Canadians.…”
    Get full text
    Article
  10. 170

    Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases by Yiyuan Xiao, Sihua Xu, Wenyan Hu, Jiapeng Huang, Deke Jiang, Rong Na, Zhaoqing Yin, Jingjing Zhang, Haitao Chen

    Published 2025-01-01
    “…Introduction and Objectives: Recently, Delphi consensus proposed an overarching term steatotic liver disease (SLD), with various subcategories such as MASLD, MetALD and ALD. …”
    Get full text
    Article
  11. 171

    Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease by Emmanouil Nychas, Andrea Marfil-Sánchez, Xiuqiang Chen, Mohammad Mirhakkak, Huating Li, Weiping Jia, Aimin Xu, Henrik Bjørn Nielsen, Max Nieuwdorp, Rohit Loomba, Yueqiong Ni, Gianni Panagiotou

    Published 2025-01-01
    “…Abstract Background The pathogenesis of non-alcoholic fatty liver disease (NAFLD) with a global prevalence of 30% is multifactorial and the involvement of gut bacteria has been recently proposed. …”
    Get full text
    Article
  12. 172
  13. 173

    Short Telomere Length in Plasma of Sudanese Patients with Hepatocellular Carcinoma and Chronic Liver Diseases by Fayza A. Rahamtalla, Iman M. Shammat, Salma B. M. Mudawi, Maram Abbas, Mohammed A. H. Kheir Elsid, Mohammed S. M. Abdalla

    Published 2024-12-01
    “…The current cross-sectional study aims to investigate the TL in the plasma of Sudanese patients with hepatocellular carcinoma (HCC) and chronic liver diseases (CLD). Methods: Blood samples were obtained from 113 patients with HCC and CLD as well as from 50 healthy controls. …”
    Get full text
    Article
  14. 174

    Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression by Hwa Young Ahn, Hwan Hee Kim, Ji-Yeon Hwang, Changhun Park, Bo Youn Cho, Young Joo Park

    Published 2018-01-01
    “…Nonalcoholic fatty liver disease or steatohepatitis (NAFLD/NASH) is a fatty liver disease that is closely related to obesity, diabetes, and dyslipidemia. …”
    Get full text
    Article
  15. 175
  16. 176

    Outcomes Following Liver Transplantation for Patients with Alcohol- Versus Nonalcohol-Induced Liver Disease by Dory Abosh, Barry Rosser, Kelly Kaita, Rose Bazylewski, Gerald Minuk

    Published 2000-01-01
    “…OBJECTIVE: To document and compare the outcomes of adult patients who received liver transplants for alcohol- and nonalcohol-induced liver diseases who attended a liver transplantation follow-up clinic in an urban, nontransplantation centre at a time when no formal alcohol abuse program for transplant candidates and/or recipients was offered.…”
    Get full text
    Article
  17. 177
  18. 178

    Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases by Shan-jing Xu, Li-ping Ye, Wei Wang, Ya-hong Chen, Jian Dong, Xin-li Mao, Shao-wei Li

    Published 2021-01-01
    “…Liver disease is a severe health problem that endangers human health worldwide. …”
    Get full text
    Article
  19. 179

    The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator? by Daniel S. Smyk, Athanasios Mavropoulos, Giorgina Mieli-Vergani, Diego Vergani, Marco Lenzi, Dimitrios P. Bogdanos

    Published 2018-01-01
    “…The role of iNKT cells in autoimmune liver disease (AiLD) has not been extensively studied. …”
    Get full text
    Article
  20. 180

    Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A by Mingliang Zhang, Xiaomin Nie, Yeqing Yuan, Yansu Wang, Xiaojing Ma, Jun Yin, Yuqian Bao

    Published 2021-01-01
    “…Previous studies have found that treatment with uncarboxylated osteocalcin can protect mice from high-fat diet-induced nonalcoholic fatty liver disease (NAFLD). However, the potential mechanisms remain unclear. …”
    Get full text
    Article